CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 2.720
-0.020 (-0.73%)
At close: Mar 6, 2026
CANbridge Pharmaceuticals Employees
CANbridge Pharmaceuticals had 45 employees as of June 30, 2025.
Employees
45
Change
n/a
Growth
n/a
Revenue / Employee
1.52M HKD
Profits / Employee
-3.31M HKD
Market Cap
1.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 45 | - | - |
| Dec 31, 2024 | 67 | -33 | -33.00% |
| Dec 31, 2023 | 100 | -17 | -14.53% |
| Dec 31, 2022 | 117 | -66 | -36.07% |
| Dec 31, 2021 | 183 | 32 | 21.19% |
| Mar 31, 2021 | 151 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Mabpharm | 383 |
| Cutia Therapeutics | 298 |
| Zhaoke Ophthalmology | 270 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 195 |
| Immunotech Biopharm | 173 |
| Kintor Pharmaceutical | 136 |
| Beijing Biostar Pharmaceuticals | 131 |
| Wuhan YZY Biopharma | 106 |
CANbridge Pharmaceuticals News
- 7 months ago - China's Push To Expand Access To Costly Therapies And A Partnership Deal Boost Rare Drugs Maker - But Is It Enough? - Benzinga